Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries Training Course (Nov 12th - Nov 13th, 2025)" has been added to ...

(MENAFN- GlobeNewsWire - Nasdaq) Nanoparticle technology offers significant opportunities in pharma and biomedicine, particularly in drug delivery, diagnostics, and therapeutic innovations. With ...

AUSTIN, Texas and TOKYO, Oct. 3, 2025 /PRNewswire/ -- According to DataM Intelligence, the Active Pharmaceutical Ingredients Market Size reached US$ 238.7 Billion in 2024, up from US$ 224.7 Billion in ...

TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced the launch of its new enhanced content search and sourcing capability, a ...

After walking away from cell therapy and narrowing its focus to just three modalities, Takeda is doubling down on its remaining strategic commitment by reupping a pact with AI drug designer Nabla Bio.

The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

From regulatory reforms to rewarding research and discoveries instead of patients treated, the existing ecosystem needs many changes to be future-ready Every headline about Donald Trump’s tariffs ...

Biotechnology is transforming natural health products. Advanced methods improve plant extract purity and potency. This ...

For more than a decade, Boston has been the undisputed capital of the world’s life sciences industry. No other city really comes close. There is more lab space in Boston and Cambridge than anywhere in ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

The U.S. government has awarded Kernal Bio and three other sub-awardees up to $48 million to help advance the biotech’s in vivo mRNA-encoded CAR T-cell program. In an interesting—if not somewhat ...

Shares of Spruce Biosciences, Inc. (NASDAQ:SPRB) are surging Monday after the biotech company shared an important regulatory update about one of its therapy treatments. What To Know: Spruce ...